a public good project by the
Synthesis
Company
of California

© 2026

Everard G.B. Vijverberg | doi.page

0 works0 citations0 h-index

Everard G.B. Vijverberg

Mount Sinai Hospital(US)Amsterdam Neuroscience(NL)Amsterdam University Medical Centers(NL)Vrije Universiteit Amsterdam(NL)

Publications by Year

Research Areas

Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Amyotrophic Lateral Sclerosis Research, Traumatic Brain Injury Research, Traumatic Brain Injury and Neurovascular Disturbances

Most-Cited Works

→ Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial(2023)293 cited
→ Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders(2020)292 cited
→ The Alzheimer’s disease drug development landscape(2021)135 cited
→ Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy(2022)131 cited
→ Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum(2018)124 cited
→ Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface(2022)121 cited

→ Diagnostic Accuracy of MRI and Additional [ 18 F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes(2016)90 cited

→ Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders(2017)45 cited

→ Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome(2016)42 cited

→ The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes(2018)41 cited